Apreo Health | $130,000,000 | (Aug 12, 2025)
Orbital Operations | $8,800,000 | (Aug 12, 2025)
Perle | $9,000,000 | (Aug 12, 2025)
Certified by Founder
Lodge
DotBio
start up
Singapore
- Singapore
- 07/08/2023
- Pre Series A
- $5,600,000
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com
- Industry Biotechnology Research
- Website https://www.dotbio.com/
- LinkedIn https://www.linkedin.com/company/dotbio/about/
Edumentors | $2,000,000 | (Aug 12, 2025)
August Health | $29,000,000 | (Aug 12, 2025)
BinSentry | $50,000,000 | (Aug 12, 2025)
Lava | $5,800,000 | (Aug 12, 2025)
Certivity | $15,458,285 | (Aug 12, 2025)
Swirltex Inc. | $1,200,000 | (Aug 12, 2025)
Tahoe Therapeutics | $30,000,000 | (Aug 12, 2025)
Neuralzome Cybernetics | $2,400,000 | (Aug 12, 2025)
Translucent(US) | $7,000,000 | (Aug 12, 2025)